Lacosamide - CAS# 175481-36-4


Catalog No. Size PriceQuantity
M10723-2 Contact sales@xcessbio.com for quotation $100
M10723-10 Contact sales@xcessbio.com for quotation $100

Description

Lacosamide, also known as ADD 243037 and SPM 927, is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat. Lacosamide is discontinued (DEA controlled substance).

Product information

CAS Number: 175481-36-4

Molecular Weight: 250.29

Formula: C13H18N2O3

Synonym:

Vimpat

Erlosamide

Chemical Name: (2R)-N-benzyl-2-acetamido-3-methoxypropanamide

Smiles: CC(=O)N[C@H](COC)C(=O)NCC1C=CC=CC=1

InChiKey: VPPJLAIAVCUEMN-GFCCVEGCSA-N

InChi: InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: Soluble in DMSO

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

References:

  1. Hawkes MA, Fernández Suárez M, Ugarnes G, D'Giano C. Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review. Clin Neuropharmacol. 2013 Jul-Aug;36(4):138-40.

Products are for research use only. Not for human use.

Payment & Security

PayPal Venmo

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed